Status:

COMPLETED

A Trial of MitoQ for the Treatment of People With Parkinson's Disease

Lead Sponsor:

Antipodean Pharmaceuticals, Inc.

Conditions:

Parkinson's Disease

Eligibility:

All Genders

30+ years

Phase:

PHASE2

Brief Summary

In Parkinson's Disease, the mitochondrial membranes in cells that produce dopamine become damaged by oxidants, leading to the death of these cells and progressive tremor, slowness of movement and the ...

Eligibility Criteria

Inclusion

  • Informed consent
  • 30 yrs or older
  • Diagnosis of PD (2 or more of bradykinesia; rest tremor, rigidity)
  • Adequate contraceptive measures (females)

Exclusion

  • Malignancy within last 2 years
  • Pregnancy \& breast-feeding
  • Treatment with any anti-PD drugs within 30 days of enrolment
  • Prior treatment with anti-PD medication exceeding 42 days in total
  • Medication-induced PD/PD not of idiopathic origin
  • CoQ10/idebenone doses of 300mg/day or higher within 120 days, \>25mg/day within 7 days of enrolment
  • Methylphenidate HCl, neuroleptics, reserpine, amphetamines, selegeline or MAOIs within 6 months of enrolment
  • CNS medications at unstable doses within 60 days of enrolment
  • Dietary supplements \> 5 x RDI
  • Hypersensitivity to CoQ10, idebenone or any components of the study drug
  • Unable to swallow
  • Diseases with features of PD
  • Seizure(s) within 12 months prior to enrolment
  • UPDRS tremor score of 4
  • Hamilton Depression Rating Scale score \> 10
  • History of stroke
  • Requirement for dopaminergic drugs
  • Modified Hoehn \& Yahr score \> 2.5
  • History of brain surgery for Parkinson's disease
  • History of structural brain disease / congenital brain abnormality
  • History of ECT
  • Any other clinically significant medical or psychiatric condition or lab abnormality
  • Enrolment in any other pharmacological study within 30 days of enrolment

Key Trial Info

Start Date :

May 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2007

Estimated Enrollment :

128 Patients enrolled

Trial Details

Trial ID

NCT00329056

Start Date

May 1 2006

End Date

November 1 2007

Last Update

July 21 2010

Active Locations (13)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (13 locations)

1

Westmead Hospital

Sydney, New South Wales, Australia

2

The Royal Brisbane and Women's Hospital

Brisbane, Queensland, Australia

3

Austin Hospital

Melbourne, Victoria, Australia

4

Dunedin Hospital

Dunedin, Otago, New Zealand